Moximed MISHA Knee wins FDA clearance, finally.

By

"After $183M in funding and 17 years of work, and 4 redesigns of the device, Moximed has finally won FDA clearance. This is why I hate the Class III pathway in orthopedics." --Tiger

Full Press Release Below

FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis

Implantable shock absorber (ISA) relieves pain and improves function in people ineligible for, or unwilling to undergo, joint replacement
MISHA Knee System is implanted during an outpatient procedure; it's the first and only device of its kind for people with symp...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.